Hepatic, oxidative, and immunological alterations in adults with concomitant Schistosoma mansoni infection and alcohol abuse in an endemic area of Cameroon Authors: Emmanuelle Simo Yimgoua, Emilienne Tienga Nkondo, Ulrich Membe Femoe, Joseph Bertin Fassi-Kadji, Mérimé Christian Kenfack, Nestor Gipwe Feussom, Sara Vázquez, Louis-Albert Tchuem Tchuente, Javier Sotillo, Hermine Boukeng Jatsa Published: 2026 ABSTRACT AbstractBackgroundSchistosoma mansoni infection and chronic alcohol consumption are major public health concerns that predominantly affect the liver, yet their combined hepatic effects remain insufficiently understood. This study aimed to investigate the pathophysiological mechanisms associated with this co-exposure in an endemic setting in Cameroon.MethodsA cross-sectional analytical study was conducted in Makenéné, Cameroon, including 310 adults stratified by parasitic status and level of alcohol exposure. Infection was diagnosed using Kato–Katz and POC-CCA assays. Alcohol exposure was assessed using the Alcohol Use Disorders Identification Test (AUDIT). Hematological, liver function, oxidative, inflammatory, and fibrogenic profiles were evaluated.ResultsCompared with alcohol abuse alone, combined S. mansoni infection and alcohol abuse was associated with reduced erythrocyte and platelet indices (p < 0.05), elevated activities of AST (p < 0.001), ALP (p < 0.01), GGT (p < 0.05), AST/ALT ratio (p < 0.001), and protein concentration (p < 0.001). Relative to schistosomiasis alone, the comorbidity was associated with higher ALT and AST (p < 0.01) and GGT (p < 0.05), but lower total protein (p < 0.05). Both schistosomiasis and alcohol abuse, independently, induced oxidative stress, evidenced by increased malondialdehyde levels (p < 0.001) and decreased catalase activity, GSH, and nitrite levels. This oxidative imbalance was exacerbated in co-exposed individuals who exhibited the lowest catalase activity (p < 0.01) and GSH concentration (p < 0.05). The comorbidity was also characterized by the lowest TNF-α levels (p < 0.05) and the highest TGF-β1 levels (p < 0.001). Procollagen type III N-terminal peptide (P3NP) peaked during S. mansoni infection (p < 0.001) but was less expressed during the comorbidity (p < 0.05). Both S. mansoni infection intensity and alcohol abuse correlate positively with transaminases and malondialdehyde, but negatively with nitrite, catalase, and TNF-α. Infection correlates positively with proteins, TGF-β1, IL-10, and P3NP, while alcohol abuse negatively correlates with IL-10 and SOD.ConclusionS. mansoni infection and alcohol abuse comorbidity exacerbates liver injury beyond either condition alone, with increased liver enzymes, oxidative stress, immune imbalance, and fibrogenesis, highlighting the need for integrated public health strategies to reduce liver-related morbidity in endemic settings.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-026-13894-3.Keywords: Schistosomiasis mansoni-alcohol abuse comorbidity, Alcohol dependence score, Hematological disorders, Hepatic dysfunction, Oxidative stress, Inflammation, Fibrosis Background The liver plays a pivotal role in maintaining systemic homeostasis through its metabolic, detoxifying, and immunological functions. Its unique position at the interface between the systemic and portal circulations renders it particularly vulnerable to a wide range of infectious and toxic insults [1]. Among these, schistosomiasis and chronic alcohol consumption are major causes of hepatic morbidity, whose coexistence within the same individual may exacerbate physiological disturbances and hasten the progression to severe liver damage [2, 3]. Schistosomiasis, a parasitic disease caused by trematodes of the genus Schistosoma, remains a major public health concern in Sub-Saharan Africa, accounting for approximately 85% of global cases, the most severe manifestations, and an estimated 200,000 deaths annually [4, 5]. In Cameroon, the National Program for the Control of Schistosomiasis and Intestinal Helminthiases (NPCSIH) estimated that over 2 million people were infected in 2020 [6]. Schistosoma mansoni, the causative agent of hepatointestinal schistosomiasis, exerts its pathogenic effect through the migration and deposition of eggs within the hepatic sinusoids and portal venous branches. This process induces a granulomatous immune response and progressive periportal fibrosis, ultimately leading to disruption of hepatic microarchitecture, impairment of metabolic functions, and alterations in portal hemodynamics [7–9]. Concurrently, chronic alcohol consumption represents an increasing public health challenge. The World Health Organization estimates that 43% of the global population consumes alcohol, with more than 600 million individuals affected by alcohol-related disorders [10, 11]. In 2019, alcohol abuse was responsible for 2.6 million deaths, representing 4.7% of global mortality [11]. Cameroon ranked fourth among 49 African countries in alcohol consumption in 2019, with an average intake of 10.1 L of pure alcohol per capita among individuals aged over 15 years, more than twice the African average of 4.5 L per capita per year [11]. Ethanol and its metabolites exert direct hepatocellular toxicity through mechanisms involving excessive production of reactive oxygen species, lipid peroxidation, and activation of hepatic stellate cells. These processes contribute to the development of steatosis, necroinflammation, and fibrogenesis [3, 12, 13]. Evidence suggests that hepatotoxicity is not exclusively attributable to ethanol itself but also to other constituents of alcoholic beverages (heavy metals, methanol, aldehydes, etc.), which can differentially modulate oxidative stress and inflammatory response [14–16]. Moreover, the concurrent consumption of multiple alcoholic drinks may overload metabolic detoxification systems, particularly alcohol dehydrogenase, thereby accelerating the depletion of the antioxidant defense [3, 17]. The coexistence of schistosomiasis and alcohol abuse may potentiate hepatic dysfunction. While S. mansoni-induced fibrosis disrupts hepatic perfusion and increases parenchymal stiffening, excessive alcohol intake further amplifies oxidative stress and inflammatory imbalance. Together, these mechanisms may accelerate the progression of liver fibrosis [18]. In addition, both S. mansoni infection and alcohol abuse are associated with hematological alterations that reflect systemic response to liver injury [19, 20]. In this context, investigating the physiological disturbances associated with schistosomiasis mansoni–alcohol abuse comorbidity is essential for understanding their interplay and its role in progression to severe complications. Such an integrated and liver-centered approach may help elucidate the biological determinants of interindividual variability in schistosomiasis-related morbidity and inform context-adapted management strategies in endemic settings. Methods Study area The study was conducted in Makenéné (4°53’04’’ N, 10°47’40’’ E), a semi-rural locality in the Mbam-et-Inoubou Division of the Centre Region of Cameroon. With an area of 885 km² and a population of approximately 16,000 inhabitants, Makenéné has a dense hydrographic network including the Mock, Makombe, Makongo, and Makenéné rivers, which flow into the Noun River. Permanent marshy areas in some villages support swamp cultivation and off-season agriculture. Mock River harbors substantial populations of Biomphalaria pfeifferi, the intermediate host of S. mansoni, therefore maintaining an active parasitic life cycle [21]. The chronicity of endemic transmission in the region has been documented for several decades, with historical prevalence rates of 82% in 1987 [22], declining to 41% in 2010 [23] and 40.7% in 2019 [20]. The survey focused on the villages of Mock Centre, Mock Sud, and Carrière, located along the Mock River, as well as on the community of Baloua, whose distinctive endemic profile has been recently reported [21, 24]. Located along National Road No. 4, which links the capital city, Yaoundé, to the Western Region, Makenéné is a strategic commercial hub. This setting promotes intense economic activity and wide availability of both industrial and artisanal alcoholic beverages. The predominantly agriculture-based lifestyle is therefore closely intertwined with patterns of alcohol consumption that are deeply rooted in the local social and cultural context. A recent epidemiological survey conducted in this area reported a 17.4% prevalence of co-occurrence between S. mansoni infection and alcohol abuse [25]. Study design and sampling A cross-sectional analytical study was conducted at the community level in May 2022 in the Makenéné health area. Although S. mansoni infection affects the entire population regardless of sex or age, the present study was restricted to individuals aged 18 years and above. This inclusion criterion was defined to allow assessing alcohol consumption, for which the legal age in Cameroon is 18 years, thereby ensuring that the investigation of alcohol-related pathophysiological effects complied with ethical and legal requirements regarding minors. In the absence of prior local data on alcohol consumption prevalence, the sample size calculation was based on the prevalence of schistosomiasis. This approach ensured a sufficiently large sample to capture a representative range of alcohol exposure in the study population, enabling robust analysis of the biological effects associated with this co-exposure. The minimum sample size was calculated using the following formula: N = t² × p × (1 − p) / m, where “N” represents the sample size, “t” the coefficient corresponding to a 95% confidence interval (1.96), “p” the prevalence of intestinal schistosomiasis determined at 40.7% in 2019 in Makenéné [24], and “m” the margin of error set at 5%. This approach resulted in a required sample size of 371 participants. A total of 431 persons were recruited and underwent an epidemiological survey. Participants were excluded if they were pregnant, didn’t provide urine/stool and blood samples, had acute/chronic diseases, or had received antibiotic treatment within the 3 months before the study. Thus, following thorough sample verification and review of medical histories, a total of 310 participants were included in the study. The study was approved by the Regional Committee of Research Ethics for Human Health of the Centre region, under the authority of the Ministry of Public Health of Cameroon (CE N° 213/CRERSHC/2022). Authorization to conduct the study was granted by the Ndikinimeki Health District, which monitors the Makenéné Health Area (N° 005–21/AE/MSP/DRSPC/DSN). All participants provided written informed consent before inclusion in the study. Samples and data were codified to ensure participants’ confidentiality. The results of parasitological and biochemical analyses were communicated to participants individually. In accordance with World Health Organization guidelines, all individuals diagnosed with S. mansoni infection received free treatment with praziquantel administered as a single dose of 40 mg/kg [5]. In parallel, a community sensitization component was conducted, emphasizing schistosomiasis prevention and raising awareness about the health risks associated with excessive alcohol consumption. Questionnaire Epidemiological data were collected using a structured digital interview questionnaire uploaded to the Survey 123 platform. The survey was administered by trained field epidemiologists familiar with the instrument and digital data-collection procedures, thereby ensuring standardized interviews. Responses were monitored in real time by field supervisors to guarantee data completeness and accuracy. In addition to sociodemographic characteristics (age, sex), the survey placed particular emphasis on two components essential to the pathophysiological analysis: assessment of alcohol consumption and medical history. AUDIT questionnaire The AUDIT (Alcohol Use Disorders Identification Test) questionnaire is a tool developed by the World Health Organization to provide a standardized estimate of alcohol consumption level, dependence-related behaviors, and alcohol-associated problems over the preceding twelve months [26]. Each participant in the study underwent an individual, structured interview to ensure accurate understanding of the ten items in the AUDIT questionnaire. Medical history A thorough review of participants’ medical history was conducted to identify potential confounding factors. Data collected included acute or chronic diseases, as well as recent schistosomicidal or other treatment. This clinical assessment allowed a more precise characterization of the cohort and helped ensure that the observed biological alterations were primarily attributable to the combined effects of schistosome infection and alcohol abuse. Determination of alcohol consumption scores Alcohol consumption was assessed using a dual approach combining a clinical alcohol dependence score and an alcohol consumption frequency score. Determination of the alcohol dependence score Each response of the AUDIT questionnaire was scored on a scale from 0 to 4. The total score, defined as the Alcohol Dependence Score (ADS), ranges from 0 to 40. It allows classification of participants into four categories: no alcohol consumption (ADS = 0), moderate consumption (ADS = 1–6), hazardous consumption (ADS = 7–12), and probable dependence (ADS ≥ 13). These four categories were consolidated into two classes: normal alcohol use (ADS ≤ 6) and alcohol abuse (ADS ≥ 7) [27]. Determination of the alcohol consumption frequency score Conceptual framework To assess the effect of alcohol exposure on biological alterations, independently of dependence-related behaviors measured by the AUDIT questionnaire, alcohol exposure was quantified using the alcohol consumption frequency score (ACFS). This approach was chosen to overcome the challenges associated with accurately estimating the volume of pure ethanol intake in a setting characterized by heterogeneous drinking patterns and the widespread consumption of unrecorded artisanal beverages, for which alcohol concentration and container volumes are highly variable and not standardized [28]. It became important to determine the ACFS to appreciate the physiological alterations associated with alcohol intake frequency. Epidemiological evidence indicates that, beyond overall biological alterations, and particularly in chronic conditions such as liver fibrosis, the frequency and regularity of alcohol consumption, as well as the type of alcoholic beverages consumed, are independent determinants of risk, regardless of the total volume ingested [14, 15]. Accordingly, the use of frequency-based scores calibrated to local drinking patterns constitutes a methodologically appropriate approach for assessing exposure and estimating the risk of hepatic morbidity [29]. Within this conceptual framework, the alcohol consumption frequency score (ACFS) was developed to generate a standardized measure of alcohol exposure adapted to local conditions. Preliminary, a systematic inventory was conducted in major shops and drinks stalls to identify alcoholic beverages available in the community, including both industrially distributed products and locally produced artisanal drinks. At the end of the survey, seven beverages were identified and included in the ACFS calculation. They included, among industrialized products: beer, wine (red or white), spirits, and adulterated whisky, and among traditional beverages: palm wine, “cha” (a maize turbid beer), and “odontol” (made from palm wine, sugar, and a tree bark). Accordingly, the specific alcohol consumption frequency score (sACFS) was established for each beverage. This approach is particularly useful for differentiating the effects of unrecorded alcoholic beverages, often containing toxic congeners due to uncontrolled fermentation, from those of industrial beverages produced under regulated and standardized conditions [28]. Calculation of the Alcohol Consumption Frequency Score (ACFS) Based on the AUDIT questionnaire, an additional item was incorporated into the field survey interview to assess the frequency of consumption for each type of alcoholic beverage, recognizing that participants may consume more than one type. The specific Alcohol Consumption Frequency Score (sACFS) was calculated by converting self-reported drinking frequencies into a continuous variable expressed as the number of drinking occasions per week. Each response was scored on a scale from 0 to 7. To ensure consistency with the civil calendar, one month is equivalent to 4.34 weeks, allowing monthly frequencies to be converted into weekly values. For each response category, the assigned score was the mean of the corresponding frequency interval, following conventional approaches to quantifying ordinal categorical data. The sACFS was therefore calculated as shown in Table 1. Table 1Determination of the Specific Alcohol Consumption Frequency Score (sACFS)Response categoryScore assignedsACFSNever0 / 4.340Once a month or less1 / 4.340.232 times a month to once a week[(2 / 4.34) + (1 / 1)] / 20.732 to 3 times a week(2 + 3) / 22.504 to 5 times a week(4 + 5) / 24.50Almost every day(6 + 7) / 26.50 Determination of the Specific Alcohol Consumption Frequency Score (sACFS) Given that multiple-beverage consumption was the predominant drinking pattern in the study areas, the alcohol consumption frequency score (ACFS) for each participant was calculated as the arithmetic sum of the specific ACFS (sACFS) corresponding to each beverage consumed: , where 1 to 7 represent the seven beverages. Diagnosis of schistosomiasis Participants were provided with two sterile containers for a separate collection of stool and urine samples. Urine samples were used for the on-site diagnosis of S. mansoni by the Point-of-Care Circulating Cathodic Antigen (POC-CCA) rapid test. Stool samples were transported to the laboratory of the Makenéné Sub-district Health Center, with systematic processing of all samples within 24 h for the Kato-Katz technique. Out of the 310 participants enrolled in the study, 268 provided stool samples, 159 provided urine samples, and 117 provided both stool and urine samples. Detection of circulating cathodic antigens of S. mansoni was performed on freshly collected urine samples (less than 15 min after collection) using a POC-CCA rapid diagnostic test (Rapid Medical Diagnostics, Pretoria, South Africa, lot no. 211110105). Stool samples were used to identify parasite eggs using a single thick smear prepared according to the Kato-Katz technique with a standardized 41.7 mg template [30]. A participant was considered S. mansoni-infected if at least one of the two diagnostic methods yielded a positive result. Infection intensity was expressed as eggs per gram of stool (EPG). Group allocation After diagnosis of schistosomiasis and determination of the level of alcohol consumption, participants were divided into four groups according to their status for each condition: S.m − and NAU (control group): S. mansoni-negative participants with normal alcohol use; S.m − and NAU (control group): S. mansoni-negative participants with normal alcohol use; S.m − and AA (alcohol abuse group): S. mansoni-negative participants with alcohol abuse; S.m − and AA (alcohol abuse group): S. mansoni-negative participants with alcohol abuse; S.m + and NAU (schistosomiasis group): S. mansoni-positive participants with normal alcohol use; S.m + and NAU (schistosomiasis group): S. mansoni-positive participants with normal alcohol use; S.m + and AA (comorbidity group): S. mansoni-positive participants with alcohol abuse. S.m + and AA (comorbidity group): S. mansoni-positive participants with alcohol abuse. Blood sample collection, processing, and storage Blood samples were collected from each participant at home by a qualified laboratory technician from the Makenéné Sub-district Health Center. Venous blood was drawn using BD Vacutainer needles into dry tubes and 5 mL EDTA tubes. Only sterile, single-use materials were employed to ensure participant safety and sample integrity. Blood samples were transported in a cooler containing ice packs to the Makenéné Sub-district Health Center laboratory. Blood in dry tubes was centrifuged at 3,500 rpm for 15 min (Centrifuge MCL0201, serial number MC2407001), and serum was stored at -20 °C during fieldwork. After completion of field activities, serum samples were transported in a cooler with ice packs to the Centre for Schistosomiasis and Parasitology (CSP) in Yaoundé. Upon arrival, serum samples were stored at -70 °C until use. An aliquot was used to quantify liver function biomarkers and oxidative stress biomarkers. Another aliquot was sent to the Parasitology Reference and Research Laboratory at the National Centre for Microbiology of the Health Institute Carlos III, Madrid, Spain, for immunological assays. Blood in EDTA tubes was transported to the Ndikinimeki hospital for hematological analysis. Due to energy supply disturbances in that area, only 154 samples were assayed. Evaluation of biological parameters Blood count The complete blood count was carried out on whole blood collected in EDTA tubes within 6 h of sampling. Analyses were performed using a Mindray BC-2800 hematology analyzer (Mindray Bio-Medical Electronics Co., Ltd., China), which enables the determination of 19 hematological parameters and provides both quantitative and morphological evaluation of the erythrocyte, leukocyte, and platelet lineages. According to the World Health Organization classification [31], the severity of anemia was determined among participants with combined S. mansoni infection and alcohol abuse. Quantification of liver function biomarkers Assessment of liver function was based on the measurement of serum liver enzyme activities using commercial BIOLABO kits (BIOLABO SAS, 02160 Maizy, France), in accordance with the manufacturer’s instructions. The enzymes analyzed included aspartate aminotransferase (AST; ref. 92025) and alanine aminotransferase (ALT; ref. 92027), quantified using a colorimetric method, as well as gamma-glutamyl transferase (GGT; ref. 81210) and alkaline phosphatase (ALP; ref. 92214), measured using a kinetic method [32]. Total protein concentration was also determined by the Biuret method as described by Gornall et al. [33]. Measurement of oxidative stress biomarkers As a component of oxidative stress, we evaluated lipid peroxidation by measuring malondialdehyde (MDA) concentrations as described by Wilbur et al. [34]. We also assessed the production of reactive nitrogen species by determining the concentration of nitrites using the Griess reagent [35]. The antioxidant profile was evaluated through the measurement of reduced glutathione concentration using the Ellman reagent [36], superoxide dismutase activity according to the protocol of Misra and Fridovich [37], and catalase activity as described by Sinha [38]. Assays of serum cytokines, CXCL8, and procollagen type III N-terminal peptide Serum cytokines (TNF-α, IL-10, and TGF-β1), a chemokine (CXCL8), and the procollagen type III N-terminal peptide (P3NP) concentrations were measured by ELISA sandwich, using commercial kits following the manufacturers’ protocols. The following kits were used for the assays: Human TNF-alpha Standard TMB ELISA Development Kit (PeproTech, lot: 1124T025), Human IL-10 Uncoated ELISA Kit (Invitrogen, lot: 437575-002), Human/Mouse TGF beta 1 Uncoated ELISA Kit (Invitrogen, lot: 423082-003), Human IL-8 (CXCL8) Standard TMB ELISA Development Kit (PeproTech, lot: 1124T018), and the Human N-Terminal Procollagen III Propeptide ELISA Kit (Invitrogen, lot: WU13VTPL4666). Data were acquired on a plate reader, and a hyperbola regression formula was used to calculate sample concentrations from the standard curves. Statistical analysis Statistical analyses were performed using GraphPad Prism version 8.0.1 (GraphPad Software, San Diego, California, USA). Kolmogorov–Smirnov and Shapiro–Wilk normality tests were applied to assess the distribution of continuous variables. Variables not following a normal distribution were expressed as median (interquartile range), and non-parametric tests were used for comparative analyses. Comparisons between two independent groups were performed using the Mann–Whitney test, whereas comparisons involving more than two groups were conducted using the Kruskal–Wallis test. When significant differences were detected, post hoc comparisons were performed using Dunn’s test to identify groups with statistically significant differences. Statistical significance was set at p < 0.05 for all analyses. Correlations between biochemical variables, parasite intensity, and alcohol consumption scores were assessed using Spearman’s correlation coefficient with SPSS (Statistical Package for the Social Sciences) version 27. Statistical significance was set at p < 0.05. Results Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the hematological profile Variation of the leukogram parameters Schistosoma mansoni infection was associated with a high percentage of lymphocytes (p < 0.05) and a low percentage of neutrophils compared to the uninfected group (p < 0.05). Similarly, in the S. mansoni infection and alcohol abuse comorbidity group, the percentage of lymphocytes increased compared to that of the alcohol abusers alone (p < 0.01), while the percentage of neutrophils decreased (p < 0.01). Alcohol abuse was not associated with any variation of leucogram parameters (Table 2). Table 2Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the leukogramWBC(109/µL)Lymphocytes (109/µL)Neutrophils (109/µL)Mixed cells (109/µL)Lymphocytes%Neutrophils%Mixed cells% Schistosomiasis S.m –6.1 (5.0–7.0)2.0 (1.6–2.4)3.5 (2.7–4.2)0.6 (0.5–0.8)31.5 (27.8–34.5)57.3 (53.9–60.9)10.7 (9.8–12.5)S.m +6.1 (5.1–7.8)2.0 (1.7–2.6)3.5 (2.7–4.2)0.7 (0.5–0.9)33.3 (29.5–39.7)*54.3 (48.7–58.8)*11.1 (9.6–13.1) Alcohol consumption NAU6.5 (4.9–7.6)2.0 (1.7–2.7)3.5 (2.7–4.3)0.7 (0.5–0.9)32.9 (29.2–38.6)55.6 (50.3–59.3)11.2 (9.7–13.0)AA6.0 (5.1–7.5)2.0 (1.7–2.5)3.5 (2.8–4.1)0.7 (0.5–0.8)32.7 (29.3–38.2)56.2 (49.3–60.2)10.8 (9.6–13.0) Schistosomiasis-alcoholism comorbidity S.m − and NAU6.1 (4.8–7.1)2.0 (1.7–2.8)3.4 (2.5–4.2)0.6 (0.5–0.8)33.5 (30.0–35.7)55.8 (53.5–59.4)10.0 (9.5–11.9)S.m − and AA6.0 (5.1–6.8)1.9 (1.6–2.3)3.5 (2.9–4.2)0.7 (0.5–0.9)30.1 (26.5–33.2)58.2 (54.2–61.3)11.1 (10.0–12.7)S.m + and NAU6.5 (5.1–7.9)2.0 (1.7–2.6)3.7 (2.7–4.5)0.7 (0.5–1.0)32.3 (28.6–38.6)55.5 (50.2–59.3)11.5 (9.8–13.4)S.m + and AA5.8 (5.1–7.8)2.0 (1.7–2.6)3.5 (2.6–4.1)0.7 (0.5–0.8)34.7 (30.5–41.7)ββ53.5 (48.1–58.4)ββ10.5 (9.0–13.0)WBC: white blood cells; Mixed cells: basophils, eosinophils, and monocytes. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). *p < 0.05: significant difference between S.m − and S.m+, ββp < 0.01: significant difference between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA) Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the leukogram WBC: white blood cells; Mixed cells: basophils, eosinophils, and monocytes. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). *p < 0.05: significant difference between S.m − and S.m+, ββp < 0.01: significant difference between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA) Variation of the erythrogram parameters As shown in Table 3, participants with S. mansoni infection, regardless of their status of alcohol use, expressed significantly lower hemoglobin concentration (p < 0.001), mean corpuscular volume (MCV) (p < 0.05), mean corpuscular hemoglobin (MCH) (p < 0.001), mean corpuscular hemoglobin concentration (MCHC) (p < 0.001), and red cell distribution width (RDW) (p < 0.001). In contrast, erythrogram parameters: hemoglobin (p < 0.01), hematocrit (p < 0.01), MCV (p < 0.05), and MCH (p < 0.05) were higher in participants with alcohol abuse, regardless of their infectious status (AA group), compared to their respective control (NAU group). Table 3Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the erythrogramRBC (1012/µL)Hemoglobin(g/L)Hematocrit(%)MCV(fL)MCH(pg)MCHC(g/L)RDW-CV(%) Schistosomiasis S.m –4.0 (3.8–4.3)122.0 (108.0–131.5)32.2 (29.8–34.4)80.6 (74.1–84.5)30.1 (26.9–32.7)376.0 (357.5–387.5)13.0 (12.0–14.0)S.m +4.2 (3.8–4.5)106.0 (92.0–121.5)***31.8 (29.0–34.5)76.0 (73.6–81.0)*24.4 (22.8–30.5)***323.0 (305.0–378.0)***12.0 (11.0–13.0)*** Alcohol consumption NAU4.1 (3.7–4.4)105.5 (89.8–123.8)30.6 (28.7–33.7)76.1 (71.1–81.2)26.1 (21.9–31.1)333.5 (303.3–383.3)12.0 (12.0–14.0)AA4.2 (3.8–4.5)117.0 (101.0–131.0)##32.4 (30.1–34.8)##78.0 (74.3–82.9)#29.0 (23.9–31.9)#354.0 (318.0–385.3)12.0 (11.0–13.0) Schistosomiasis-alcoholism comorbidity S.m − and NAU4.1 (3.7–4.2)118.0 (107.0–129.0)30.7 (29.7–34.5)79.6 (71.6–83.9)29.8 (27.0–32.7)376.0 (358.0–388.0)13.0 (12.0–15.0)S.m − and AA4.0 (3.8–4.4)124.5 (110.3–132.0)32.6 (30.1–34.4)80.7 (75.0–84.7)30.2 (26.3–32.9)375.0 (355.3–387.8)13.0 (12.0–14.0)S.m + and NAU4.1 (3.7–4.4)99.0 (87.5–114.5)α30.5 (28.3–32.9)75.4 (70.4–80.1)23.8 (21.2–30.6)α318.0 (302.0–375.5)αα12.0 (11.0–13.5)αS.m + and AA4.3 (3.8–4.6)108.5 (97.3–123.5)β32.3 (30.1–35.5)76.5 (74.1–81.9)25.0 (23.3–30.5)β323.5 (309.8–379.8)β12.0 (11.0–13.0)αα.βRBC: red blood cells; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW-CV: red cell distribution width, coefficient of variation. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). *p < 0.05, ***p < 0.001: significant differences between S.m − and S.m+. #p < 0.05, ##p < 0.01: significant differences between NAU and AA. αp < 0.05, ααp < 0.01: significant differences with the control group (S.m − and NAU). βp < 0.05: significant difference between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA) Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the erythrogram RBC: red blood cells; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW-CV: red cell distribution width, coefficient of variation. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). *p < 0.05, ***p < 0.001: significant differences between S.m − and S.m+. #p < 0.05, ##p < 0.01: significant differences between NAU and AA. αp < 0.05, ααp < 0.01: significant differences with the control group (S.m − and NAU). βp < 0.05: significant difference between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA) Schistosoma mansoni-alcohol abuse comorbidity was associated with a significant reduction in red cell distribution width (RDW-CV) (p < 0.01). When erythrogram parameters were compared between participants with comorbidity (S.m + and AA) and those with alcohol abuse only (S.m − and AA), the comorbidity group showed significantly lower hemoglobin concentration (p < 0.05), mean corpuscular hemoglobin (MCH) (p < 0.05), mean corpuscular hemoglobin concentration (MCHC) (p < 0.05), and red cell distribution width (RDW) (p < 0.05). In contrast, no significant differences in erythrogram indices were observed between the comorbidity group and participants with schistosomiasis and normal alcohol use (S.m + and NAU) (Table 3). Anemia recorded among participants with S. mansoni infection and alcohol abuse comorbidity was a homogeneous microcytic hypochromic anemia, characterized by lowered mean corpuscular volume, mean corpuscular hemoglobin concentration, and red blood cell distribution width. The use of haemoglobin concentrations to assess anaemia in participants with concurrent S. mansoni infection and alcohol abuse showed that the overall prevalence of anaemia was 73.1%. Moderate anemia was the most frequent (48.1%), followed by mild (21.2%) and severe (3.8%) anemia. Sex-stratified analysis showed that moderate anemia predominated in men (53.1%), with no severe cases observed. However, among women, moderate anemia accounted for 40.0% of cases, while mild and severe forms affected 25.0% and 10.0% of participants, respectively (Fig. 1). Distribution of anemia severity among participants with Schistosoma mansoni infection and alcohol abuse comorbidity Hemoglobin thresholds to define anemia severity in adults (15–65 years old) are as follows: (1) No anemia: ≥ 120 g/L for non-pregnant women, and ≥ 130 g/L for men. (2) Mild anemia: 110–119 g/L for non-pregnant women, and 110–129 g/L for men. (3) Moderate anemia: 80–109 g/L for non-pregnant women and men. (4) Severe anemia: < 80 g/L for non-pregnant women and men. Correlation between alcohol consumption and hemoglobin concentration Higher alcohol intake was significantly associated with higher hemoglobin concentration within the study population, whether assessed using the alcohol consumption frequency score (ACFS: ρ = 0.199; p = 0.014) or the alcohol dependence score (ADS: ρ = 0.258; p = 0.001). Wine consumption showed a significant correlation with hemoglobin levels (ρ = 0.437; p < 0.001), followed by spirits (ρ = 0.290; p < 0.001) and beer (ρ = 0.218; p = 0.007). A similar positive correlation was observed among S. mansoni-infected participants, but not among those who were S. mansoni-negative. In the latter group, only wine intake remained positively correlated with hemoglobin concentration (ρ = 0.277; p = 0.044) (Table 4). Table 4Correlation between alcohol consumption and hemoglobin concentration according to the beverage types and alcohol consumption scores (ACFS, ADS)VariablesSpearmancorrelationBeerWineSpiritsAdulterated whiskyPalm wine“Odontol”“Cha”ACFSADSTotal populationρ0.218**0.437***0.290***0.1350.0700.0120.1090.199*0.258**p-value0.007< 0.001< 0.0010.0940.3850.8850.1770.0140.001S.m+ρ0.206*0.408***0.297**0.1440.1000.0900.0700.213*0.222*p-value0.038< 0.0010.0030.1510.3180.3720.4890.0330.026S.m−ρ0.1340.277*0.074-0.0760.018-0.2280.1020.0760.127p-value0.3390.0440.5990.5870.8990.1000.4670.5900.367ρ: correlation coefficient. The two-tailed correlation analysis was based on 154 data points for the total population, 101 for S. mansoni-infected participants, and 53 for S. mansoni-negative. Significant two-tailed correlation at *p < 0.05; **p < 0.01 and ***p < 0.001Palm wine, “Odontol”, and “Cha” are traditional beverages. “Odontol” is made from palm wine, sugar, and tree bark. “Cha” is a maize turbid beer. ACFS: alcohol consumption frequency score; ADS: alcohol dependence score. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use Correlation between alcohol consumption and hemoglobin concentration according to the beverage types and alcohol consumption scores (ACFS, ADS) ρ: correlation coefficient. The two-tailed correlation analysis was based on 154 data points for the total population, 101 for S. mansoni-infected participants, and 53 for S. mansoni-negative. Significant two-tailed correlation at *p < 0.05; **p < 0.01 and ***p < 0.001 Palm wine, “Odontol”, and “Cha” are traditional beverages. “Odontol” is made from palm wine, sugar, and tree bark. “Cha” is a maize turbid beer. ACFS: alcohol consumption frequency score; ADS: alcohol dependence score. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use Variation of the thrombogram parameters Participants infected with S. mansoni, irrespective of alcohol consumption, exhibited significantly lower platelet counts (p < 0.01), mean platelet volume (MPV) (p < 0.001), plateletcrit (PCT) (p < 0.001), and platelet distribution width (PDW) (p < 0.001) compared with S. mansoni-negative participants. When both conditions were considered simultaneously, participants with schistosomiasis–alcohol abuse comorbidity (S.m + and AA) showed significantly lower platelet distribution width (PDW) than controls (S.m − and NAU) (p < 0.01) and alcohol abusers without schistosomiasis (S.m − and AA) (p < 0.05). Plateletcrit was also depleted compared with that of alcohol abusers without schistosomiasis (p < 0.05) (Table 5). Table 5Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the thrombogramPlatelets (103/µL)MPV (fL)PCT (%)PDW (fL) Schistosomiasis S.m –215.0 (186.0–257.0)11.0 (9.1–12.8)0.23 (0.18–0.32)19.4 (16.1–27.7)S.m +185.0 (136.5–234.0)**9.4 (8.4–10.6)***0.16 (0.11–0.24)***15.8 (14.8–19.0)*** Alcohol consumption NAU196.0 (132.5–234.0)9.6 (8.4–11.6)0.18 (0.11–0.27)16.6 (15.0–21.0)AA208.0 (165.3–239.8)10.0 (8.8–12.3)0.20 (0.14–0.28)16.3 (14.8–27.7) Schistosomiasis-alcoholism comorbidity S.m − and NAU212.0 (179.0–257.0)10.9 (9.3–12.8)0.21 (0.18–0.31)19.6 (17.0–27.7)S.m − and AA216.0 (188.8–258.0)11.2 (9.0–12.8)0.24 (0.18–0.32)19.0 (15.9–27.7)S.m + and NAU178.0 (130.0–233.0)9.2 (8.3–10.6)α0.15 (0.10–0.23)15.8 (14.8–18.4)ααS.m + and AA193.5 (148.3–238.0)9.6 (8.7–11.0)0.17 (0.12–0.24)β15.6 (14.8–20.0)αα, βMPV: mean platelet volume; PCT: plateletcrit (platelet volume relative to total blood volume); PDW: platelet distribution width. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). **p < 0.01, ***p < 0.001: significant differences between S.m − and S.m+. αp < 0.05, ααp < 0.01: significant differences compared with the control group (S.m − and NAU). βp < 0.05: significant difference between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA) Impact of Schistosoma mansoni infection-alcohol abuse comorbidity on the thrombogram MPV: mean platelet volume; PCT: plateletcrit (platelet volume relative to total blood volume); PDW: platelet distribution width. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). **p < 0.01, ***p < 0.001: significant differences between S.m − and S.m+. αp < 0.05, ααp < 0.01: significant differences compared with the control group (S.m − and NAU). βp < 0.05: significant difference between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA) Impact of Schistosoma mansoni infection–alcohol abuse comorbidity on the liver function Variation of the liver function biomarkers Assessment of liver function biomarkers showed significantly elevated activities of alanine aminotransferase (ALT) (p < 0.01), aspartate aminotransferase (AST) (p < 0.001), alkaline phosphatase (ALP) (p < 0.001), and gamma-glutamyl transferase (GGT) (p < 0.001), as well as the AST/ALT ratio (p < 0.001) and total protein concentration (p < 0.001) in S. mansoni-positive participants, regardless of their alcohol consumption. Similarly, alcohol abusers exhibited significantly higher activities of liver enzymes ALT (p < 0.001), AST (p < 0.001), and GGT (p < 0.001); however, they showed reduced total protein concentrations (p < 0.001), irrespective of their parasitic status (Fig. 2A, B, C, D, E). Variation of liver function biomarkers in Schistosoma mansoni infection-alcohol abuse comorbidity. ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transferase. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). **p < 0.01, ***p < 0.001: significant differences between S.m − and S.m+. ###p < 0.001: significant difference between NAU and AA. αp < 0.05, ααp < 0.01, αααp < 0.001: significant differences compared with the control group (S.m − and NAU). βp < 0.05, ββp < 0.01, βββp < 0.001: significant differences between the comorbidity group (S.m + and AA) and the alcohol abuse group (S.m − and AA). γp < 0.05, γγp < 0.01: significant differences between the comorbidity group (S.m + and AA) and the schistosomiasis group (S.m + and NAU) Participants with S. mansoni infection-alcohol abuse comorbidity (S.m + and AA) exhibited significantly higher enzyme activities than those without schistosomiasis and with normal alcohol use (S.m − and NAU), including increases in 89% of ALT (p < 0.001), 161% of AST (p < 0.001), 23% of ALP (p < 0.05), and 92% of GGT (p < 0.001) activities, as well as, a 20% of the AST/ALT ratio (p < 0.01). ALT, AST, and GGT activities were also significantly higher in participants with the comorbidity than in those positive to S. mansoni but without excessive alcohol intake (p < 0.01). Likewise, AST activity, the AST/ALT ratio, and ALP activity were significantly greater in the comorbidity group than in alcohol abusers without schistosomiasis (p < 0.001) (Fig. 2A, B, C, D, E). However, the total protein concentration in the comorbidity group was significantly higher than that observed in the alcohol abuse group (p < 0.001) but lower than in the schistosomiasis-only group (p < 0.05) (Fig. 2F). Association between liver function biomarkers and Schistosoma mansoni infection intensity and alcohol consumption scores The correlation analysis between hepatic biomarkers and parasitic burden revealed positive and significant associations between parasite load and increased activities of ALT (ρ = 0.241, p < 0.001), AST (ρ = 0.310, p < 0.001), ALP (ρ = 0.172, p = 0.005), as well as, higher total protein concentration (ρ = 0.325, p < 0.001) (Table 6). Table 6Correlations between liver function biomarkers and parasite burden, alcohol consumption frequency scores, and alcohol dependence scoreVariablesSpearman correlationALTASTAST/ALTALPGGTTPParasite burdenρ0.241**0.310**0.181**0.172**0.1090.325**p-value< 0.001< 0.0010.0030.0050.076< 0.001sACFSBeerρ0.291**0.274**0.021-0.0180.192**-0.270**p-value< 0.001< 0.0010.7130.7530.001< 0.001Wineρ0.234**0.166**-0.014-0.121*0.021-0.141*p-value< 0.0010.0040.8020.0340.7100.018Spiritsρ0.136*0.062-0.041-0.0400.095-0.132*p-value0.0170.2800.4780.4880.0980.027Adulterated whiskyρ0.123*0.018-0.126*-0.0510.160**-0.196**p-value0.0310.7570.0280.3740.0050.001Palm wineρ0.220**0.314**0.137*0.0640.354**-0.221**p-value< 0.001< 0.0010.0170.262< 0.001< 0.001“Odontol”ρ0.169**0.074-0.0980.0200.189**-0.105p-value0.0030.2000.0880.7240.0010.079“Cha”ρ0.131*0.084-0.0230.0670.088-0.150*p-value0.0220.1430.6920.2450.1280.012ACFSρ0.296**0.321**0.0800.0030.340**-0.284**p-value< 0.001< 0.0010.1620.952< 0.001< 0.001ADSρ0.481**0.380**-0.035-0.0250.254**-0.348**p-value< 0.001< 0.0010.5420.659< 0.001< 0.001 Correlations between liver function biomarkers and parasite burden, alcohol consumption frequency scores, and alcohol dependence score Analysis of correlations between liver function biomarkers and the specific alcohol consumption frequency score (sACFS) showed that beer, wine, and palm wine consumption were positively and significantly associated with elevated ALT and AST activities. Consumption of “cha” was positively correlated with increased ALT activity, but not with AST. In addition, higher GGT activity was positively associated with the consumption of beer (ρ = 0.192; p = 0.001), adulterated whisky (ρ = 0.160; p = 0.005), palm wine (ρ = 0.354; p < 0.001), and “odontol” (ρ = 0.189; p = 0.001). Conversely, lower total protein concentration was significantly and negatively associated with consumption of all beverages (beer, wine, spirits, adulterated whisky, palm wine, and “cha”), except “odontol”. Only wine intake was negatively correlated with increased ALP activity. (Table 6) Furthermore, the alcohol consumption frequency score (ACFS) and the alcohol dependence score (ADS) were positively and significantly associated with elevated ALT, AST, and GGT activities, while showing a negative correlation with total protein concentrations. (Table 6) ρ: correlation coefficient. The two-tailed correlation analysis included between 240 and 307 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01. ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transferase; TP: total proteins. Palm wine, “Odontol”, and “Cha” are traditional beverages. “Cha” is a maize turbid beer, and “Odontol” is made from palm wine, sugar, and a tree bark. sACFS: specific alcohol consumption frequency score; ACFS: alcohol consumption frequency score; ADS: alcohol dependence score. Impact of Schistosoma mansoni infection–alcohol abuse comorbidity on the oxidative status Variation of the oxidative stress biomarkers S. mansoni-infected participants and those with alcohol abuse exhibited a similar oxidative stress profile irrespective of their alcohol consumption and parasitic status. Both conditions were associated with significantly increased malondialdehyde (MDA) levels, together with decreased catalase activity and reduced concentrations of glutathione (GSH) and nitrites. This pattern was consistently observed in S. mansoni-negative participants with alcohol abuse, and S. mansoni-positive participants with normal alcohol use (Fig. 3A, B, D, E). Additionally, superoxide dismutase (SOD) activity was significantly lower among alcohol abusers (p < 0.01) (Fig. 3C). Variation of oxidative stress biomarkers in Schistosoma mansoni infection-alcohol abuse comorbidity. SOD: superoxide dismutase. S.m−: S. mansoni-negative participants, regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status. S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). *p < 0.05. **p < 0.01. ***p < 0.001: significant differences between S.m − and S.m+. #p < 0.05, ##p < 0.01, ###p < 0.001: significant differences between NAU and AA. αp < 0.05, ααp < 0.01, αααp < 0.001: significant differences compared with the control group (S.m − and NAU). βp < 0.05; significant difference between the comorbidity group (S.m + and AA) and the alcoholism group (S.m − and AA). γγp < 0.01: significant difference between the comorbidity group (S.m + and AA) and the schistosomiasis group (S.m + and NAU) In participants presenting S. mansoni infection and alcohol abuse comorbidity, MDA levels were approximately fivefold higher than in S. mansoni-negative individuals with normal alcohol consumption (p < 0.001), while nitrite concentrations were reduced by 44% (Fig. 3A, B). Antioxidant defense was also markedly impaired in this group, with significant reductions of 31% in SOD activity (p < 0.05), 29% in catalase activity (p < 0.001), and 38% in GSH levels (p < 0.001) (Fig. 3C, D, E). Furthermore, catalase activity in comorbid participants was lower than in those with schistosomiasis alone (p < 0.05), whereas GSH concentration was reduced compared with participants with alcohol abuse alone (p < 0.001) (Fig. 3D, E). Association between oxidative stress biomarkers and Schistosoma mansoni infection intensity and alcohol consumption scores Spearman’s correlation analysis identified several significant associations between oxidative stress biomarkers and parasite burden, alcohol consumption frequency scores (sACFS and ACFS), and alcohol dependence score (ADS) (Table 7). Table 7Correlations between oxidative stress biomarkers and parasite burden, alcohol consumption frequency scores, and alcohol dependence scoreVariablesSpearman correlationMDANitritesSODCatalaseGSHParasite burdenρ0.210**-0.192**-0.128-0.237**-0.060p-value0.0020.0030.058< 0.0010.352sACFSBeerρ0.139*-0.225**-0.125*-0.284**-0.010p-value0.030< 0.0010.044< 0.0010.867Wineρ-0.010-0.227**-0.177**-0.240**0.092p-value0.876< 0.0010.004< 0.0010.126Spiritsρ-0.091-0.172**-0.160**-0.206**0.121*p-value0.1550.0040.0100.0010.042Adulterated whiskyρ-0.073-0.074-0.058-0.179**0.013p-value0.2560.2130.3550.0030.825Palm wineρ0.107-0.193**-0.025-0.167**-0.036p-value0.0960.0010.6930.0060.548“Odontol”ρ0.059-0.0860.025-0.0660.078p-value0.3550.1510.6850.2730.194“Cha”ρ-0.042-0.035-0.065-0.0450.121*p-value0.5120.5610.2960.4610.042ACFSρ0.101-0.220**-0.073-0.253**0.001p-value0.116< 0.0010.244< 0.0010.986ADSρ0.244**-0.336**-0.226**-0.426**-0.007p-value< 0.001< 0.001< 0.001< 0.0010.901ρ: correlation coefficient. The two-tailed correlation analysis included between 207 and 281 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01MDA: malondialdehyde; SOD: superoxide dismutase; GSH: reduced glutathione. Palm wine. “Odontol”. and “Cha” are traditional beverages. “Cha” is a maize turbid beer. and “Odontol” is made from palm wine. sugar. and a tree bark. sACFS: specific alcohol consumption frequency score; ACFS: alcohol consumption frequency score; ADS: alcohol dependence score Correlations between oxidative stress biomarkers and parasite burden, alcohol consumption frequency scores, and alcohol dependence score ρ: correlation coefficient. The two-tailed correlation analysis included between 207 and 281 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01 MDA: malondialdehyde; SOD: superoxide dismutase; GSH: reduced glutathione. Palm wine. “Odontol”. and “Cha” are traditional beverages. “Cha” is a maize turbid beer. and “Odontol” is made from palm wine. sugar. and a tree bark. sACFS: specific alcohol consumption frequency score; ACFS: alcohol consumption frequency score; ADS: alcohol dependence score Malondialdehyde (MDA) was positively correlated with parasite burden (ρ = 0.210; p = 0.002). In contrast, nitrite levels (ρ = −0.192; p = 0.003) and catalase activity (ρ = −0.237; p < 0.001) were inversely associated with parasite burden. At the level of specific beverages (sACFS), MDA level was positively associated with beer consumption (ρ = 0.139; p = 0.030), while nitrite concentration was negatively correlated with the consumption of beer (ρ = −0.225; p < 0.001), wine (ρ = −0.227; p < 0.001), spirits (ρ = −0.172; p = 0.004), and palm wine (ρ = −0.193; p = 0.001). Regarding antioxidant defense, the activities of antioxidant enzymes such as SOD and catalase showed significant negative correlations with the consumption of beer, wine, and spirits. Additionally, catalase activity was negatively correlated with the consumption of adulterated whisky (ρ = −0.179; p = 0.003) and palm wine (ρ = −0.167; p = 0.006). In contrast, GSH levels showed significant positive correlations with spirits (ρ = 0.121; p = 0.042) and “cha” (ρ = 0.121; p = 0.042). Analysis of the alcohol consumption frequency score (ACFS) and the alcohol dependence score (ADS) further supported these findings. It reveals significant negative correlations between ACFS and nitrite concentration (ρ = −0.220; p < 0.001) and catalase activity (ρ = −0.253; p < 0.001). Significant negative correlations were also observed between ADS and nitrite levels (ρ = −0.336; p < 0.001), SOD activity (ρ = −0.226; p < 0.001), and catalase activity (ρ = −0.426; p < 0.001). Conversely, MDA levels were positively correlated with ADS (ρ = 0.244; p < 0.001). Association between oxidative stress and liver function biomarkers The analysis of the relationship between oxidative stress and liver function biomarkers revealed positive correlations between MDA levels and ALT activity (ρ = 0.434; p < 0.001), AST activity (ρ = 0.451; p < 0.001), and GGT activity (ρ = 0.154; p = 0.016). In contrast, nitrite levels were negatively correlated with ALT (ρ = −0.468; p < 0.001) and AST (ρ = −0.305; p < 0.001) (Table 8). Table 8Correlations between oxidative stress biomarkers and liver function biomarkersVariablesSpearman correlationALTASTAST/ALTALPGGTTPMDAρ0.434**0.451**0.0350.0210.154*0.087p-value< 0.001< 0.0010.5830.7420.0160.183Nitritesρ-0.468**-0.305**0.098-0.075-0.0780.004p-value< 0.001< 0.0010.1000.2110.1930.952SODρ-0.221**-0.203**-0.0210.0340.038-0.126*p-value< 0.0010.0010.7320.5880.5450.046Catalaseρ-0.376**-0.236**0.093-0.043-0.0520.060p-value< 0.001< 0.0010.1250.4810.3890.326GSHρ-0.070-0.144*-0.144*-0.141*-0.092-0.039p-value0.2460.0160.0160.0180.1250.530ρ: correlation coefficient. The two-tailed correlation analysis included between 239 and 281 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma glutamyltransferase; TP: total proteins; MDA: malondialdéhyde; SOD: superoxide dismutase; GSH: reduced glutathione Correlations between oxidative stress biomarkers and liver function biomarkers ρ: correlation coefficient. The two-tailed correlation analysis included between 239 and 281 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01 ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma glutamyltransferase; TP: total proteins; MDA: malondialdéhyde; SOD: superoxide dismutase; GSH: reduced glutathione Regarding antioxidant defense, SOD and catalase activities were negatively and significantly correlated with ALT and AST, and with total protein concentration (ρ = −0.126; p = 0.046) for SOD only. GSH concentration was also negatively correlated with AST activity (ρ = −0.144; p = 0.016), AST/ALT ratio (ρ = −0.144; p = 0.016), and ALP activity (ρ = −0.141; p = 0.018) (Table 8). Impact of Schistosoma mansoni infection–alcohol abuse comorbidity on the inflammatory response Variation of the levels of some cytokines, a chemokine, and a fibrotic factor S. mansoni-infected participants, irrespective of alcohol consumption status, exhibited significantly lower TNF-α levels compared with uninfected participants (p < 0.001). Similarly, participants with either schistosomiasis and normal alcohol use (p < 0.01) or alcohol abuse without schistosomiasis (p < 0.05) showed decreased levels of TNF-α relative to controls. Notably, individuals with combined S. mansoni infection and alcohol abuse had the lowest TNF-α concentration, showing a 39% reduction compared with controls (p < 0.001), and an approximately 25% decrease compared with alcohol abusers without S. mansoni infection (p < 0.05) (Fig. 4A). Variation of the levels of some cytokines, CXCL8, and P3NP in Schistosoma mansoni infection-alcohol abuse comorbidity. TNF-α: tumor necrosis factor-α. TGF-β1: transforming growth factor β1. IL-10: interleukin 10. CXCL8: C-X-C motif chemokine ligand 8 (IL-8: interleukin 8). P3NP: procollagen type III N-terminal peptide. S.m−: S. mansoni-negative participants regardless of their alcohol use; S.m+: S. mansoni-positive participants, regardless of their alcohol use; NAU: participants with normal alcohol use, regardless of their S. mansoni infectious status; AA: participants with alcohol abuse, regardless of their S. mansoni infectious status; S.m − and NAU: S. mansoni-negative participants with normal alcohol use (control group); S.m − and AA: S. mansoni-negative participants with alcohol abuse (alcohol abuse group); S.m + and NAU: S. mansoni-positive participants with normal alcohol use (schistosomiasis group); S.m + and AA: S. mansoni-positive participants with alcohol abuse (comorbidity group). **p < 0.01. ***p < 0.001: significant differences between S.m − and S.m+. #p < 0.05: significant difference between NAU and AA. αp < 0.05, ααp < 0.01, αααp < 0.001: significant differences compared with the control group (S.m − and NAU). βp < 0.05. βββp < 0.001: significant differences between the comorbidity group (S.m + and AA) and the alcoholism group (S.m − and AA). γp < 0.05: significant difference between the comorbidity group (S.m + and AA) and the schistosomiasis group (S.m + and NAU) TGF-β1 levels were approximately twofold higher in S. mansoni-positive participants, compared with uninfected individuals, regardless of their alcohol consumption level (p < 0.01). Among participants with S. mansoni infection and alcohol abuse comorbidity, TGF-β1 concentrations were markedly elevated: 3.5 times higher than in controls (p < 0.05), and 4.5 times higher than in participants with alcohol abuse alone (p < 0.001) (Fig. 4B). In contrast, no significant differences were observed for IL-10 and CXCL8, regardless of infection status, alcohol consumption level, or their co-occurrence (Fig. 4C, D). Procollagen type III N-terminal peptide (P3NP) concentrations were 31% higher in participants with S. mansoni infection compared with uninfected individuals, irrespective of alcohol consumption level (p < 0.01). Among S. mansoni-positive participants with normal alcohol use, P3NP levels increased by 56% relative to the uninfected group (p < 0.001), and by 31% compared with those presenting S. mansoni infection-alcohol abuse comorbidity (p < 0.05) (Fig. 4E). Association between cytokines, CXCL8, P3NP, and S. mansoni infection intensity and level of alcohol consumption Correlation analysis revealed significant associations between cytokines, P3NP, and parasite burden. A negative correlation was observed for TNF-α levels (ρ = −0.324; p < 0.001), while positive correlations were displayed for TGF-β (ρ = 0.278; p < 0.001), IL-10 (ρ = 0.258; p < 0.001), and P3NP (ρ = 0.278; p < 0.001) (Table 9). Table 9Correlations between cytokines, CXCL8, P3NP, and parasite burden, alcohol consumption frequency scores, and alcohol dependence scoreVariablesSpearman correlationTNF-αTGF-βIL-10CXCL8P3NPParasite burdenρ-0.324**0.278**0.258**-0.0090.278**p-value< 0.001< 0.001< 0.0010.900< 0.001sACFSBeerρ-0.107-0.020-0.057-0.0460.027p-value0.0670.7290.3290.4590.704Wineρ-0.141*0.008-0.001-0.0520.055p-value0.0160.8890.9860.4070.435Spiritsρ-0.0440.005-0.053-0.024-0.011p-value0.4560.9270.3640.7040.877Adulterated whiskyρ-0.0430.070-0.026-0.0840.057p-value0.4630.2280.6530.1750.419Palm wineρ-0.1060.034-0.076-0.082-0.012p-value0.0710.5630.1900.1890.869“Odontol”ρ-0.0710.0350.037-0.0160.057p-value0.2270.5530.5290.7990.421“Cha”ρ-0.0340.105-0.003-0.0580.009p-value0.5640.0710.9650.3550.900ACFSρ-0.0830.023-0.072-0.124*0.013p-value0.1590.6910.2150.0450.860ADSρ-0.171**-0.051-0.115*-0.102-0.004p-value0.0030.3820.0490.1020.956ρ: correlation coefficient. The two-tailed correlation analysis included between 219 and 297 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01TNF-α: tumor necrosis factor-α. TGF-β1: transforming growth factor β1. IL-10: interleukin 10. CXCL8: C-X-C motif chemokine ligand 8 (IL-8: interleukin 8). P3NP: procollagen type III N-terminal peptide. sACFS: specific alcohol consumption frequency score. ACFS: alcohol consumption frequency score. ADS: alcohol dependence score. Palm wine. “Odontol”. and “Cha” are traditional beverages. “Cha” is a maize turbid beer. and “Odontol” is made from palm wine. sugar. and a tree bark Correlations between cytokines, CXCL8, P3NP, and parasite burden, alcohol consumption frequency scores, and alcohol dependence score ρ: correlation coefficient. The two-tailed correlation analysis included between 219 and 297 data points. Significant two-tailed correlation at *p < 0.05 and **p < 0.01 TNF-α: tumor necrosis factor-α. TGF-β1: transforming growth factor β1. IL-10: interleukin 10. CXCL8: C-X-C motif chemokine ligand 8 (IL-8: interleukin 8). P3NP: procollagen type III N-terminal peptide. sACFS: specific alcohol consumption frequency score. ACFS: alcohol consumption frequency score. ADS: alcohol dependence score. Palm wine. “Odontol”. and “Cha” are traditional beverages. “Cha” is a maize turbid beer. and “Odontol” is made from palm wine. sugar. and a tree bark Regarding alcohol consumption patterns, no significant correlations were observed between cytokines, CXCL8, P3NP, and the frequency of consumption of specific alcoholic beverages. An exception was noted for TNF-α levels, which were inversely correlated with wine intake (ρ = −0.141; p = 0.016). In addition, CXCL8 concentrations were negatively associated with the alcohol consumption frequency score (ACFS) (ρ = −0.124; p = 0.045). Similarly, TNF-α (ρ = −0.171; p = 0.003) and IL-10 (ρ = −0.115; p = 0.049) exhibited negative correlations with the alcohol dependence score (ADS) (Table 9). Discussion The combined effects of S. mansoni infection and alcohol abuse are poorly documented, despite both being significant health challenges. While each condition independently contributes to liver disease, the pathophysiological consequences of their coexistence remain poorly investigated. This gap is important because the liver is both a key metabolic organ and an immunological crossroads [13, 39]. S. mansoni infection and alcohol abuse affect the liver through different but potentially complementary mechanisms. Investigating these combined effects in an endemic S. mansoni area in Cameroon will not only advance scientific understanding but also inform clinical management of liver health in populations exposed to both parasitic infection and alcohol-related toxicity. The examination of hematological parameters is the first step of this analysis, revealing how alcohol interferes with the classical clinical manifestations of parasitic infection. In participants with concomitant S. mansoni infection and alcohol abuse, the observed decreases in hemoglobin concentration, MCH, MCHC, and RDW-CV compared with alcohol abusers likely reflect the convergence of distinct physiological mechanisms affecting iron metabolism and erythropoiesis. S. mansoni infection induces microcytic hypochromic anemia, classically associated with iron deficiency, which results from multifactorial mechanisms [40]. Beyond the direct hematophagy of adult worms, trans-intestinal egg migration induces mucosal damage followed by repeated micro-hemorrhages, leading to occult blood loss in the stool. This depletion could be further exacerbated by the sequestration of circulating red blood cells within an enlarged, congested spleen resulting from schistosomiasis-induced portal hypertension, as well as by inflammation associated with the infection [41]. These overall mechanisms lead to reduced iron availability for erythropoiesis and hypochromic microcytosis. In contrast, the increased hemoglobin concentration and elevated MCH and MCHC in alcohol abusers suggest an alteration of iron homeostasis. Hemoconcentration may partly explain this finding, particularly through ethanol’s diuretic effects and the resulting fluctuations in plasma volume. In this study, hemoglobin concentrations were positively associated with wine and spirits consumption. It has been reported that the bioavailability of non-heme iron in wine is enhanced by ethanol [42]. Alcohol abuse also promotes increased intestinal iron absorption through the mobilization of ferritin stores, the suppression of hepcidin, and the upregulation of intestinal iron transporters, including the divalent metal transporter-1 (DMT1) and ferroportin-1 (FPN1) [43]. Indeed, ethanol inhibits hepatic synthesis of hepcidin, the key regulator of systemic iron balance, thus reducing its concentration and promoting increased iron availability [44]. Alcohol-induced suppression of hepcidin leads to increased expression of DMT1 and FPN1 as reported in biopsies from patients with alcoholic liver disease [45], explaining enhanced intestinal iron absorption. The positive correlations between hemoglobin concentration and both alcohol consumption frequency score (ACFS) and alcohol dependence score (ADS) suggest that the elevated hemoglobin levels in alcohol abusers are not attributable to occasional intake but, instead, reflect cumulative exposure and chronic alcohol burden. S. mansoni infection and alcohol abuse comorbidity results in a significant reduction in MCH and MCHC compared with alcohol abusers, suggesting that the iron-restricted profile of schistosomiasis predominates over alcohol-induced iron loading, thereby inducing an important blood loss and impairing hemoglobin synthesis. This finding is consistent with the concept of functional iron deficiency, in which iron is present but not effectively utilized for erythropoiesis. This analysis supports the high 73% prevalence of anemia registered in the population of comorbid participants. Furthermore, the decrease in their RDW-CV compared to controls and alcohol abusers, and similarly to S. mansoni-positive participants, indicates that the superimposition of schistosomiasis appears to drive the system toward a more uniform population of smaller and less hemoglobinized red cells [19]. The comorbid participants also exhibited low platelet distribution width (PDW) and plateletcrit (PCT), as did the S. mansoni-positive participants, in addition to low platelet counts and reduced mean platelet volume (MPV). This profile suggests not only thrombocytopenia but also reduced platelet size and heterogeneity. Thrombocytopenia has been reported in chronic S. mansoni schistosomiasis and is attributed to parasite-induced hypersplenism, which promotes platelet sequestration [19, 46]. Moreover, the architecture of the fibrotic liver acts as a mechanical filter, preferentially retaining larger platelets [46]. This blood depletion of large functional platelets has a direct implication on hemostatic efficiency, contributing to the persistence of infection. This fact is also maintained by the schistosomes themselves, which secrete specific enzymes such as ATP diphosphohydrolase (SmATPDase1), locally inhibiting platelet aggregation [47, 48]. In contrast, chronic alcohol consumption does not induce marked thrombocytopenia or major alterations in platelet morphology. However, reduced PCT and PDW remain in the schistosomiasis-alcohol abuse comorbidity, suggesting that alcohol does not fully counteract schistosomiasis-induced alterations in platelet size and heterogeneity. The hematological profile of S. mansoni-infected participants and those with the comorbidity also revealed an increase in lymphocyte percentage, accompanied by a decrease in neutrophil proportion. This pattern is consistent with the well-described chronic Th2-polarized immune response characteristic of schistosomiasis, driven by persistent antigenic stimulation from parasite eggs [49, 50]. The leukocyte counts and mixed cells, including eosinophils, remain relatively stable, as in alcohol abusers and comorbid participants. Overall, the leukogram suggests a balanced, immunomodulated state, rather than acute inflammation. In chronic S. mansoni infection, the immune response typically shifts from an early Th1 pro-inflammatory phase to a Th2 regulatory profile. Among the study population, we observed a decrease in TNF-α across S. mansoni infection, alcohol abuse, and their comorbidity. TNF-α reduction among infected patients was proportional to parasite burden, indicating a more pronounced Th2 polarization, classically associated with high parasite loads. This polarization is characterized by increased production of IL-4, IL-10, and TGF-β. These cytokines exert inhibitory effects on Th1 cytokines such as TNF-α to limit excessive tissue damage caused by egg-induced granulomatous acute inflammation [50, 51]. In parallel, the independent decrease in TNF-α associated with alcohol abuse further supports the immunosuppressive properties of chronic ethanol exposure. Indeed, in alcoholic hepatitis, alcohol inhibits monocyte/macrophage activation, reducing NF-κB signaling and altering cytokine gene expression. This leads to diminished production of pro-inflammatory mediators, including TNF-α [52]. The marked reduction of TNF-α in the comorbid group suggests an additive, or even synergistic effect of S. mansoni infection and alcohol abuse, leading to enhanced immunosuppression and attenuation of pro-inflammatory responses. It is important to emphasize that this modulation does not correspond to generalized inhibition of inflammation, as CXCL8 concentrations remained stable. The primary role of CXCL8 in neutrophil recruitment is more relevant to acute inflammation, as it’s produced by Kupffer cells in response to TNF-α and toll-like receptor (TLR) ligands through NF-κB activation [53]. Therefore, chronic schistosomiasis and alcohol exposure may not modulate its systemic levels, or opposing regulatory mechanisms may maintain its stability. In parallel, IL-10 showed a positive correlation with parasite burden, with no significant increase among infected individuals. This finding supports the concept of a burden-dependent IL-10-mediated regulatory signal, whereby significant anti-inflammatory signaling is triggered only when antigenic stimulation becomes sufficiently high [54]. Lower TNF-α levels have been associated with disease progression and fibrosis. The central driver of hepatic fibrosis, TGF-β1, was significantly higher in S. mansoni-infected participants proportionally to parasite burden and reached its highest levels in S. mansoni infection and alcohol abuse participants. In schistosomiasis, TGF-β1 is the key driver of hepatic stellate cells activation and extracellular matrix deposition, contributing to periportal fibrosis [55]. Activated stellate cells increase extracellular matrix production, including type III procollagen, via Smad signaling pathways. During collagen maturation, cleavage of terminal extensions releases the procollagen type III N-terminal peptide (P3NP) fragments into circulation, making this peptide a direct marker of active fibrogenesis [56, 57]. The elevated levels of P3NP in S. mansoni-infected participants confirm increased collagen turnover and active liver fibrosis. On the other hand, the positive correlation between P3NP, TGF-β1, and parasite burden reinforces the central role of S. mansoni eggs-induced granulomas-driven fibrogenic signaling. An unexpected finding in this study is that alcohol abusers did not exhibit significant increases in TGF-β1 or P3NP levels compared with controls, and these markers were not correlated with alcohol consumption scores. Despite the well-established profibrogenic role of TGF-β1 in alcoholic liver diseases [58], the unchanged circulating levels of TGF-β1 among alcohol abusers in this study may be explained by its paracrine and autocrine effects within the liver. Its systemic concentrations may therefore not accurately reflect intrahepatic fibrogenic activity [59]. Concomitantly, circulating PIIINP may remain within normal ranges in mild or heterogeneous disease, particularly in cross-sectional studies, where cumulative changes over time may not be captured [60]. Another plausible explanation lies in the immunosuppressive effect of alcohol. Chronic alcohol exposure inhibits protein synthesis through disruption of mTOR and eIF2α pathways, leading to a global reduction in protein production at the systemic levels, probably including TGF-β1 and structural matrix proteins (P3NP) [61, 62]. This is confirmed by the significant decrease in total protein levels of the alcohol abuse participants and the correlation of this biomarker with the alcohol consumption scores. This paradox may contribute to the absence of detectable differences in circulating TGF-β1 and P3NP in alcohol abusers, despite ongoing subclinical hepatic alterations. Importantly, these findings contrast with the marked elevation of TGF-β1 in participants with concomitant S. mansoni infection and alcohol abuse, in the absence of a parallel increase in P3NP levels. The absence of fibrosis markers in alcohol abuse participants strengthens the hypothesis that the pronounced fibrogenic profile observed in co-exposed individuals may result from a synergistic amplification of upstream fibrogenic signaling rather than a simple additive effect. Concurrently, the lack of a parallel rise in serum P3NP indicates that enhanced profibrotic signaling does not necessarily result in a proportional increase in systemic extracellular matrix deposition. Several mechanisms may explain this discrepancy. Chronic ethanol exposure is known to impair cellular homeostasis and may alter the responsiveness of hepatic stellate cells to TGF-β1. Indeed, data suggest that prolonged alcohol exposure can disrupt ECM turnover by simultaneously promoting fibrogenic signals and impairing matrix assembly or stability [63]. Hepatic fibrogenesis is a dynamic process governed by the balance between ECM synthesis and degradation. Increased activity of matrix metalloproteinases (MMPs) may counterbalance collagen deposition, leading to stable P3NP levels despite elevated circulating TGF-β1 [64]. The concomitant increase in circulating TGF-β1 and the unchanged systemic P3NP levels suggest that co-exposure to S. mansoni and alcohol promotes an amplified fibrogenic signaling environment, accompanied by dysregulation of downstream extracellular matrix remodeling processes. This may represent a transitional or dysregulated phase of fibrosis, potentially preceding more advanced liver pathology. The observed fibrogenic response in the context of S. mansoni infection and alcohol abuse suggests a concomitant involvement of oxidative stress, which may further exacerbate liver damage. It is known that both schistosome egg-induced granulomatous inflammation and chronic ethanol metabolism generate reactive oxygen species (ROS), which directly injure hepatocytes and potentiate TGF-β1-dependent stellate cell activation [57]. Our findings indicate that both S. mansoni infection, alcohol abuse, and their comorbidity, are associated with a comparable oxidative stress profile, characterized by increased lipid peroxidation and impaired antioxidant defenses. The significantly higher malondialdehyde (MDA) observed in both conditions reflects enhanced lipid peroxidation secondary to excessive ROS production by activated macrophages and eosinophils in response to parasite antigens during schistosomiasis [2, 51], or through ethanol metabolism, via alcohol dehydrogenase and the microsomal ethanol-oxidizing system involving cytochrome P450 2E1 in the case of chronic alcohol consumption [65]. The concomitant decrease in key antioxidant defenses, including catalase, superoxide dismutase (SOD), and reduced glutathione (GSH), further sustains an oxidative imbalance. In both S.mansoni infection and alcohol abuse, the depletion of antioxidant systems has been attributed to continuous ROS production, which overwhelms endogenous detoxification pathways [66]. The reduction of nitrite levels may reflect decreased nitric oxide (NO) bioavailability. Indeed, in the presence of excess superoxide radicals (O₂⁻), secondary to reduced SOD activity, NO interacts with them to form peroxynitrite (ONOO⁻), a reactive nitrogen species, further amplifying lipid peroxidation [67]. Notably, individuals with concomitant S. mansoni infection and alcohol abuse exhibited a significant exacerbation of oxidative stress, as evidenced by the five-fold increase in MDA levels compared with controls, and the substantial decline in SOD activity, catalase activity, and GSH concentrations compared with those of controls, S. mansoni-infected patients, and alcohol abusers, respectively. These findings indicate a synergistic or additive effect of schistosomiasis and alcohol abuse on oxidative damage. Such exacerbation may result from the simultaneous activation of S. mansoni-induced inflammatory pathways and alcohol-mediated metabolic stress, leading to excessive ROS production that surpasses the antioxidant buffering capacity. Similar synergistic effects have been reported in other models of combined hepatic injury, in which oxidative stress plays an important role in accelerating tissue damage and fibrogenesis [68]. The positive correlation between MDA levels and parasite burden, together with the inverse correlation between nitrite levels and parasite burden, strengthens the link between infection intensity and lipid peroxidation. Furthermore, the negative correlation between catalase activity and parasite burden suggests a progressive exhaustion of antioxidant defenses as infection severity increases. Similarly, the association between oxidative stress biomarkers and alcohol consumption scores (sACFS, ACFS, ADS) highlights a dose-dependent effect of alcohol on redox imbalance. The positive association between MDA and the alcohol dependence score (ADS), alongside the negative correlations between antioxidant defenses (SOD and catalase) and ADS, supports the well-documented relationship between chronic alcohol exposure and progressive oxidative damage [65]. Beer consumption appeared to be the principal driver of lipid peroxidation, and the intake of beer, wine, spirits, adulterated whisky, and palm wine exerted marked pressure on antioxidant defenses, suggesting that these beverages may progressively reduce enzymatic activity through sustained metabolic demand, even before overt membrane damage [17]. The consistent inverse relationship between nitrite levels and the consumption of different alcoholic beverages implies that alcohol may impair NO-related pathways, contributing to endothelial dysfunction and tissue damage [69]. These oxidative imbalances are likely to contribute to hepatic impairment, as reflected by alterations in liver function biomarkers. The most direct expression of liver injury is the massive release of transaminases (ALT and AST) into the vascular compartment. In intestinal schistosomiasis, the deposition of parasite eggs within the portal venous system triggers a sustained inflammatory response characterized by immune cell infiltration, oxidative stress, and cytokine-mediated hepatocyte injury, all of which contribute to increased transaminase leakage into the circulation [9, 51, 70]. The elevated AST/ALT ratio in S. mansoni-infected individuals may indicate a shift toward more advanced or chronic hepatic injury resulting from mitochondrial lysis exacerbation [71]. The concomitant increase in alkaline phosphatase (ALP) and γ-glutamyl transferase (GGT) activities reflects biliary involvement through profound injury to the ductular unit and canalicular membrane [72, 73]. In schistosomiasis, periovular granulomas within the portal tracts exert mechanical pressure on the bile ducts, leading to obstructive cholestasis and inducing de novo synthesis of ALP by cholangiocytes. Concurrently, pro-inflammatory cytokines modulate the expression of bile acid and bilirubin transporters. Together, these mechanisms contribute to elevated activities of cholestatic enzymes [74]. This functional cholestasis is aggravated by membrane lipid peroxidation, which disrupts GGT anchorage and facilitates its massive release into the circulation [72]. The positive correlation between liver enzyme activities (ALT, AST, ALP), AST/ALT ratio, and parasite burden reinforces the concept of a burden-dependent hepatic injury, whereby increasing egg deposition amplifies inflammatory and fibrogenic processes, leading to progressive hepatocellular and biliary damage. The increased ALT, AST, and GGT activities also registered in alcohol abusers agree with the extensive literature on alcohol-induced liver injury. Ethanol metabolism leads to the accumulation of acetaldehyde and excess NADPH, promoting hepatic steatosis that fosters inflammation and increases hepatocyte vulnerability. This injury is exacerbated by disrupted iron homeostasis, as alcohol-induced iron overload enhances hydroxyl radical generation via the Fenton reaction [75]. In parallel, alcohol impairs the intestinal barrier, facilitating translocation of Gram-negative bacteria and their endotoxins to the liver via the portal vein [76]. This influx activates Kupffer cells, thereby perpetuating oxidative stress through enhanced free radical generation and lipid peroxidation [12, 13, 77]. The resulting membrane damage ultimately leads to the release of hepatocellular enzymes into the bloodstream. GGT increase is a sensitive marker of chronic alcohol intake and is mainly related to oxidative stress, as evidenced by the positive correlation between MDA and GGT in this study. Indeed, the prooxidant effect of GGT is attributed to cysteine-glycine and cysteine that reduce ferric iron Fe(III) to ferrous Fe(II), producing ROS as coproducts of this reduction [78]. The significant positive correlation between GGT and alcohol dependence (ADS), as well as consumption frequency indices (sACFS and ACFS), highlights its relevance as a biomarker of chronic alcohol exposure. Consistently, Magzoub et al. [79] reported a proportional increase in GGT activity with the severity of alcohol intake. Transaminases activities were also positively associated with alcohol intake indices (ADS and ACFS), further supporting a dose-dependent hepatotoxic effect of alcohol. ALT increase was particularly associated with all specific beverage intake, indicating the vulnerability of hepatocellular membranes to different types of alcohol. The differential associations observed across beverage types may reflect variations in ethanol concentration, contaminants, and drinking patterns. Adulterated whisky and locally produced beverages such as palm wine and “odontol” may contain additional hepatotoxic compounds, including methanol or heavy metals, which can exacerbate liver injury [80]. These findings are consistent with previous evidence pointing out that both the quantity and type of alcohol consumed modulate the severity of liver injury [81]. In participants with concomitant S. mansoni infection and alcohol abuse, the profile of the total protein concentration was intermediate: higher than in alcohol abusers but lower than in schistosomiasis-only participants. This profile probably results from a complex interplay between inflammatory stimulation and impaired synthesis capacity. The elevated protein concentration in S. mansoni infection is likely driven by increased production of immunoglobulins and acute-phase proteins in response to chronic antigenic stimulation [82]. However, in the presence of alcohol, this response appears partially offset by compromised hepatic protein synthesis, as chronic alcohol consumption disrupts protein synthesis through endoplasmic reticulum stress, altered amino acid metabolism, and progressive hepatocellular dysfunction [83]. In parallel, the liver enzyme activities were markedly amplified in participants with S. mansoni-alcohol comorbidity, providing strong evidence of synergistic hepatotoxicity. The significant increase in ALT, AST, ALP, and GGT, as well as the AST/ALT ratio in the comorbidity group, compared with either the alcohol abuse or the schistosomiasis group, suggests that the co-occurrence of parasitic infection and alcohol exposure exacerbates both hepatocellular injury and cholestatic alterations. In this context, S. mansoni-induced granulomatous inflammation may sensitize hepatic tissue to alcohol-mediated oxidative injury. At the same time, alcohol may further impair immune regulation and tissue repair, thereby amplifying parasite-induced pathology [84]. Study limitations Some limitations should be considered when interpreting the results of this study. First, the diagnostic approach for S. mansoni infection combined the POC-CCA test for a minority of participants and the Kato-Katz technique for the majority. Differences in the diagnostic performance of these methods may have led to some degree of misclassification of infection, particularly among individuals harboring low parasite burdens. Second, although the initial sample size calculation targeted 371 participants for prevalence estimation, the final analytical dataset included 310 individuals with complete epidemiological and biological information. In addition, alcohol consumption was assessed exclusively through self-reported data, which is inherently subject to recall inaccuracies and social desirability bias. Consequently, the actual level of alcohol exposure and its contribution to the observed biological alterations may have been underestimated. Furthermore, the influence of potential confounding factors cannot be entirely excluded. Although participants with known major medical conditions were excluded, the possible influence of unrecognized comorbidities, nutritional factors, environmental hepatotoxins, or undiagnosed infections cannot be completely ruled out. The possible use of unreported traditional remedies or self-medication also represents an additional source of variability that could have influenced participants’ enzymatic and inflammatory profiles. Another limitation is the absence of endoscopic and ultrasonographic assessments, which precluded the evaluation of gastrointestinal complications and the severity of liver fibrosis among participants. In addition, the cross-sectional design does not allow for an assessment of the progression and reversibility of the observed alterations over time. Finally, caution is warranted when extrapolating these findings to other settings, as variations in alcohol consumption patterns and parasite exposure across geographical contexts may limit their generalizability. Conclusion To the best of our knowledge, this study is one of the first to characterize the hematological, biochemical, and immunological alterations underlying S. mansoni infection and alcohol abuse comorbidity in an endemic setting. This study demonstrates that the co-occurrence of S. mansoni infection and alcohol abuse leads to a more aggravated hepatic phenotype than each condition alone. This phenotype was characterized by enhanced hepatocellular injury, cholestasis, and altered protein metabolism. Moreover, comorbidity results in an amplified oxidative stress characterized by intensified lipid peroxidation and impaired antioxidant capacity. Furthermore, S. mansoni infection and alcohol abuse comorbidity was characterized by a shift toward a profibrotic and immunomodulatory environment, as reflected by elevated TGF-β1 levels and suppressed TNF-α responses. The relatively stable systemic levels of P3NP suggest a complex regulation of fibrosis. The observed correlations further support the existence of a deleterious synergy between parasite burden and alcohol intake in driving liver dysfunction, redox imbalance, and immunological reprogramming of the host response. From a clinical and public health perspective, these findings highlight the need to consider alcohol consumption in schistosomiasis-endemic settings, as it may aggravate disease progression and alter underlying pathophysiological mechanisms. Therefore, integrating alcohol screening and behavioral interventions into schistosomiasis control programs could mitigate the combined hepatotoxic effects of parasitic infection and alcohol use. Furthermore, strengthening access to endoscopic and ultrasonography screening and management of upper gastrointestinal complications associated with S. mansoni-induced portal hypertension and periportal fibrosis, alongside community-based health education initiatives and timely antischistosomal treatment, may help prevent the progression to severe hepatosplenic disease. Such integrated interventions could substantially reduce morbidity and improve clinical outcomes in endemic communities of Cameroon. Additional longitudinal studies are needed to clarify the long-term impact of S. mansoni infection and alcohol abuse comorbidity on fibrosis progression and clinical outcomes. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements The authors sincerely thank Dr Kenel Ondoua, the Ndikinimeki Health District Chief, Dr Eric Michel Bell, the chief doctor of the Makenene Sub-district Health Center, and its staff for their institutional support. We also thank the community health workers of Makenene for their role in mobilization and awareness efforts, as well as all the participants who took part in this study. Special thanks are given to laboratory technician Ms. Germaine Lieheu for her vital contribution to parasitological examinations. Abbreviations Alcohol Consumption Frequency Score Alcohol Dependence Score Alkaline Phosphatase Alanine Aminotransferase Aspartate Aminotransferase C-X-C motif Chemokine Ligand 8 Gamma-Glutamyl Transferase / Gamma-Glutamyl Transpeptidase Reduced Glutathione Interleukin-10 Mean Corpuscular Hemoglobin Mean Corpuscular Hemoglobin Concentration Mean Corpuscular Volume Malondialdehyde Mean Platelet Volume Procollagen type III N-terminal Peptide Plateletcrit Platelet Distribution Width - Coefficient of Variation Red Cell Distribution Width - Coefficient of Variation Specific Alcohol Consumption Frequency Score Superoxide Dismutase Transforming Growth Factor-β Tumor Necrosis Factor-α Total Protein White Blood Cells Author contributions HBJ, ESY, MCK, UMF, and ETN conceived and designed the study. ESY, ETN, UFM, MCK, NGF, JBF-K, and HBJ contributed to sample and data collection at the study site. ESY, ETN, UMF, and JBF-K performed biochemical assays under the supervision of HBJ. HBJ and SV performed immunological assays under the supervision of JS. ESY and HBJ contributed to data curation and analysis. HBJ, L-ATT, and JS seek the funds, and HBJ and L-ATT administered and supervised the project. ESY and HBJ wrote the manuscript, and JS reviewed it. All authors read and approved the final manuscript. Funding This work was supported by the Children’s Investment Fund Foundation (CIFF) as part of the RSTMH Small Grants Program 2021 through an award to Emmanuelle Simo Yimgoua; by the Women for Africa Foundation (Madrid, Spain) through the 9th edition of the Science by Women Fellowship to Hermine Boukeng Jatsa at the Health Institute Carlos III (ICSIII), Madrid, Spain; and by the Health Institute Carlos III, Spanish Ministry of Economy and Competitiveness (PI23CIII/00034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data availability All data generated and analyzed during this study are included in this published article and its supplementary information file. Declarations Ethics approval and consent to participate The research protocol received approval from the Regional Committee of Research Ethics for Human Health of the Centre region, under the authority of the Ministry of Public Health of Cameroon, with ethical clearance issued under reference number CE No. 213/CRERSHC/2022. Implementation of the study was also subject to administrative authorization issued by the Ndikiniméki Health District, which oversees the Makenéné health area (No. 005–21/AE/MSP/DRSPC/DSN). Field investigations were conducted with the prior assent of local administrative and traditional authorities. Each participant signed an informed consent form. The confidentiality of the collected information was ensured through systematic anonymization of data before any analytical procedures. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Emmanuelle Simo Yimgoua and Hermine Boukeng Jatsa contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement All data generated and analyzed during this study are included in this published article and its supplementary information file.